Showing 97 to 108 of 116 results


Counterfeit Weight-Loss Injections Pose Serious Health Risks in the UK
UK health officials have seized over 600 fake weight-loss injection pens since 2023, causing serious health risks like seizures and comas due to the presence of insulin instead of the intended active ingredient. The illegal sale through online platforms and beauty salons is driven by high demand and...
Counterfeit Weight-Loss Injections Pose Serious Health Risks in the UK
UK health officials have seized over 600 fake weight-loss injection pens since 2023, causing serious health risks like seizures and comas due to the presence of insulin instead of the intended active ingredient. The illegal sale through online platforms and beauty salons is driven by high demand and...
Progress
52% Bias Score


FDA Approves Zepbound for Obstructive Sleep Apnea Treatment
The FDA approved Eli Lilly's Zepbound (tirzepatide) as the first medication to treat obstructive sleep apnea in obese adults, following two successful 52-week studies demonstrating significant symptom reduction.
FDA Approves Zepbound for Obstructive Sleep Apnea Treatment
The FDA approved Eli Lilly's Zepbound (tirzepatide) as the first medication to treat obstructive sleep apnea in obese adults, following two successful 52-week studies demonstrating significant symptom reduction.
Progress
32% Bias Score


Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial
A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...
Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial
A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...
Progress
40% Bias Score


El auge de fármacos contra la obesidad reduce las cirugías bariátricas en Estados Unidos
El uso de agonistas del receptor GLP-1 para tratar la obesidad aumentó un 123% en Estados Unidos entre 2022 y 2023, mientras que las cirugías bariátricas disminuyeron un 25%, planteando un cambio en las estrategias terapéuticas y la necesidad de evaluar la combinación de ambos tratamientos.
El auge de fármacos contra la obesidad reduce las cirugías bariátricas en Estados Unidos
El uso de agonistas del receptor GLP-1 para tratar la obesidad aumentó un 123% en Estados Unidos entre 2022 y 2023, mientras que las cirugías bariátricas disminuyeron un 25%, planteando un cambio en las estrategias terapéuticas y la necesidad de evaluar la combinación de ambos tratamientos.
Progress
40% Bias Score


Wegovy Launches in China
The weight-loss drug Wegovy launches in China, offering a potentially effective treatment for the country's large obese population, but also raising questions about affordability and healthcare systems.
Wegovy Launches in China
The weight-loss drug Wegovy launches in China, offering a potentially effective treatment for the country's large obese population, but also raising questions about affordability and healthcare systems.
Progress
40% Bias Score


Losing the Last 5kg: Challenges and Solutions
A book review focusing on "5 in 4: The Art and Science of Losing Those Last Few Kilos", detailing challenges and solutions for weight loss.
Losing the Last 5kg: Challenges and Solutions
A book review focusing on "5 in 4: The Art and Science of Losing Those Last Few Kilos", detailing challenges and solutions for weight loss.
Progress
24% Bias Score

Brain's Control of Intestinal Fat Absorption Suggests New Obesity Treatments
Researchers in Shanghai discovered that the brain regulates intestinal fat absorption in mice by controlling the length of microvilli in the jejunum via the vagus nerve; inactivating the nerve's dorsal motor nucleus reduces fat absorption and weight, while activation increases it, suggesting potenti...

Brain's Control of Intestinal Fat Absorption Suggests New Obesity Treatments
Researchers in Shanghai discovered that the brain regulates intestinal fat absorption in mice by controlling the length of microvilli in the jejunum via the vagus nerve; inactivating the nerve's dorsal motor nucleus reduces fat absorption and weight, while activation increases it, suggesting potenti...
Progress
36% Bias Score

Kathy Bates Showcases Dramatic Weight Loss at Hollywood Gala
Kathy Bates, 76, displayed her 100-pound weight loss at the Hollywood Reporter's Women in Entertainment Gala in Beverly Hills on Wednesday, openly discussing her health journey and use of Ozempic, while also reflecting on ageism in Hollywood.

Kathy Bates Showcases Dramatic Weight Loss at Hollywood Gala
Kathy Bates, 76, displayed her 100-pound weight loss at the Hollywood Reporter's Women in Entertainment Gala in Beverly Hills on Wednesday, openly discussing her health journey and use of Ozempic, while also reflecting on ageism in Hollywood.
Progress
56% Bias Score

Zepbound Shows 47% Greater Weight Loss Than Wegovy in Obesity Trial
A clinical trial showed that adults using the obesity drug Zepbound lost 47% more weight on average than those using Wegovy after 18 months, achieving an average weight loss of 50 pounds compared to 33 pounds, respectively.

Zepbound Shows 47% Greater Weight Loss Than Wegovy in Obesity Trial
A clinical trial showed that adults using the obesity drug Zepbound lost 47% more weight on average than those using Wegovy after 18 months, achieving an average weight loss of 50 pounds compared to 33 pounds, respectively.
Progress
48% Bias Score

Weight-Loss Drugs: Successes and Side Effects
This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.

Weight-Loss Drugs: Successes and Side Effects
This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.
Progress
24% Bias Score

Protein and Health
This article discusses the importance of protein in our diet, explaining its various functions, types, recommended intake, and potential effects of high-protein diets.

Protein and Health
This article discusses the importance of protein in our diet, explaining its various functions, types, recommended intake, and potential effects of high-protein diets.
Progress
24% Bias Score

Healthcare Worker Nearly Dies After Using 'Skinny Jabs' from Facebook
A healthcare worker almost died after injecting weight-loss jabs bought on Facebook, raising concerns about the dangers of unregulated medications.

Healthcare Worker Nearly Dies After Using 'Skinny Jabs' from Facebook
A healthcare worker almost died after injecting weight-loss jabs bought on Facebook, raising concerns about the dangers of unregulated medications.
Progress
40% Bias Score
Showing 97 to 108 of 116 results